Avanos Medical AVNS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | ||||||
| PM&R | $7.2M+44.0% | $9.2M+241% | $7.9M+472% | $6.7M+274% | $5M+203% | |
| Total Specialty Nutrition Systems | $84.6M-2.2% | $82.6M+2.2% | $87.1M+14.9% | $82.7M+7.1% | $86.5M+14.7% | |
| Net Sales by Product | ||||||
| Enteral feeding | $324.8M+10.4% | $314.7M+8.6% | $306.7M+7.4% | $296M+4.1% | $294.2M+4.2% | |
| Neonate solutions | $131M+20.5% | $118.2M+10.8% | $117M+19.5% | $111.9M+19.4% | $108.7M+19.7% | |
| Radiofrequency ablation | $141.8M+10.3% | $139M+10.1% | $136.2M+13.9% | $132.9M+14.9% | $128.6M+15.2% | |
| Surgical pain and recovery | $96.1M-8.9% | $98.8M-8.5% | $100.8M+5.9% | $102.9M+0.1% | $105.5M-3.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
